Cargando…

Identification of prognostic inflammatory factors in colorectal liver metastases

BACKGROUND: The modified Glasgow Prognostic Score (mGPS) has been reported to be an important prognostic indicator in a number of tumor types, including colorectal cancer (CRC). The features of the inflammatory state thought to accompany elevated C-reactive protein (CRP), a key feature of mGPS, were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamilton, Trevor D, Leugner, Derek, Kopciuk, Karen, Dixon, Elijah, Sutherland, Francis R, Bathe, Oliver F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125702/ https://www.ncbi.nlm.nih.gov/pubmed/25069793 http://dx.doi.org/10.1186/1471-2407-14-542

Ejemplares similares

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma
por: Bathe, Oliver F, et al.
Publicado: (2004)

Serum metabolomic profile as a means to distinguish stage of colorectal cancer
por: Farshidfar, Farshad, et al.
Publicado: (2012)

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases
por: Bathe, Oliver F, et al.
Publicado: (2009)

Host phenotype is associated with reduced survival independent of tumour biology in patients with colorectal liver metastases
por: van Dijk, David P.J., et al.
Publicado: (2018)

Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases
por: Munene, Gitonga, et al.
Publicado: (2013)

Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of (1)H-NMR Spectroscopy and Gas Chromatography–Mass Spectrometry
por: McConnell, Yarrow J., et al.
Publicado: (2017)

Preoperative single-dose methylprednisolone versus placebo after major liver resection in adults: protocol for a randomised controlled trial
por: Bressan, Alexsander K, et al.
Publicado: (2015)

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
por: Stretch, Cynthia, et al.
Publicado: (2018)

Rupture and intra-peritoneal bleeding of a hepatocellular carcinoma after a transarterial chemoembolization procedure: a case report
por: Reso, Artan, et al.
Publicado: (2009)

Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases
por: Zhang, Tianhao, et al.
Publicado: (2021)

The Prognostic Significance of Lymphatics in Colorectal Liver Metastases
por: Muralidharan, Vijayaragavan, et al.
Publicado: (2014)

Efficacy of a dual-ring wound protector for prevention of incisional surgical site infection after Whipple's procedure (pancreaticoduodenectomy) with preoperatively-placed intrabiliary stents: protocol for a randomised controlled trial
por: Bressan, Alexsander K, et al.
Publicado: (2014)

Prognostic circulating proteomic biomarkers in colorectal liver metastases
por: Kim, Dongchan, et al.
Publicado: (2023)

Early detection of treatment futility in patients with metastatic colorectal cancer
por: Rattner, Jodi I., et al.
Publicado: (2022)

Clinical and metabolomic characterization of Brivanib‐Induced hypertension in metastatic colorectal cancer
por: Rattner, Jodi I., et al.
Publicado: (2023)

A quantitative multimodal metabolomic assay for colorectal cancer
por: Farshidfar, Farshad, et al.
Publicado: (2018)

Prognostic and Therapeutic Implications of Tumor Biology in Colorectal Liver Metastases
por: Kamphues, Carsten, et al.
Publicado: (2021)

A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
por: Farshidfar, Farshad, et al.
Publicado: (2016)

Survival time and prognostic factors of patients with initial noncurative colorectal liver metastases
por: Liu, Qizhi, et al.
Publicado: (2017)

Colorectal Liver Metastases
por: Haddad, Ashraf J., et al.
Publicado: (2011)

B Cells as Prognostic Biomarker After Surgery for Colorectal Liver Metastases
por: Hof, Joost, et al.
Publicado: (2020)

Prognostic Impact of Pedicle Clamping during Liver Resection for Colorectal Metastases
por: Schiergens, Tobias S., et al.
Publicado: (2020)

Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
por: Michal, Sternschuss, et al.
Publicado: (2021)

Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases
por: Park, Jun Su, et al.
Publicado: (2014)

Performance of variable selection methods using stability-based selection
por: Lu, Danny, et al.
Publicado: (2017)

Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer
por: Bartolini, Ilenia, et al.
Publicado: (2018)

Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases
por: Jang, Ki Ung, et al.
Publicado: (2016)

Prognostic factors and therapeutic effects of different treatment modalities for colorectal cancer liver metastases
por: Ma, Zuo-Hong, et al.
Publicado: (2020)

Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival
por: Akhan, Okan, et al.
Publicado: (2023)

Ablation therapy for patients with colorectal liver metastases with and without extrahepatic metastases: evaluation of long-term outcomes and prognostic factors
por: Klubien, Jeanett, et al.
Publicado: (2023)

BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 3: CONTROVERSIES AND UNRESECTABLE METASTASES
por: TORRES, Orlando Jorge Martins, et al.
Publicado: (2016)

Surgery for colorectal liver metastases
por: Primrose, J N
Publicado: (2010)

Treatment of colorectal liver metastases
por: Ismaili, Nabil
Publicado: (2011)

Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection
por: Liu, Yueh-Wei, et al.
Publicado: (2020)

Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases
por: Wang, En, et al.
Publicado: (2021)

BRAF Mutations in Colorectal Liver Metastases: Prognostic Implications and Potential Therapeutic Strategies
por: Wang, Pei-Pei, et al.
Publicado: (2022)

Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

Role of Serum CYFRA 21-1 in Diagnosis and Prognostic in Colorectal Liver Metastases
por: Li, Shirong, et al.
Publicado: (2023)

Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases
por: Tai, K., et al.
Publicado: (2020)

Prognostic factors of brain metastases from colorectal cancer
por: Imaizumi, Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vd3hr31ilhrk8kc0l92trqckss